A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...

Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.

Follicular lymphoma has long been considered incurable, but a study led by Wilmot Cancer Institute director Dr. Jonathan ...

Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of ...

Confirmatory trial on tazemetostat suggested a link with secondary hematologic malignancie ...

March is the awareness month for colorectal cancer and multiple myeloma. If you’re interested in speaking to experts, contact media@fredhutch.org to schedule interviews. Scientists develop ...

Tattoos may increase the risk of developing lymphoma and skin cancer, a recent study suggests. "We can see that ink particles accumulate in the lymph nodes, and we suspect that the body perceives them ...

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

MISSION VIEJO, Calif. (KABC) -- Actor Jeff Bridges announced he's fighting a major battle. The Oscar winner on Tuesday tweeted that he's been diagnosed with lymphoma. "I have been diagnosed with ...